Richard Newitter

Q: How accurate are Richard Newitter's stock ratings?

About 59% of Richard's ratings were profitable over a one-year hold, with an average return of +5.9% per rating, measured by 13Foresight from historical prices.

Q: How is Richard ranked?

Richard Newitter is ranked #1630 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Truist Financial

Wall Street Analyst

★★★☆☆

#1630

on 13Foresight · ranked by our own returns

59%

Success Rate

+6.0%

Average Return

75 of 127 calls profitable · +26.4% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 59% of Richard Newitter's ratings turned a profit when each position was held for 1 year — averaging +6.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

134 Buy 74 Hold 0 Sell

Richard's Stock Coverage 47 ratings · 2026-11-10

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
GKOS Glaukos	Oct 29, 2026	BUY	Strong Buy -18.6% avg upside 21 analysts	$255.00 7.23% Upside	-7.4%	·
VCEL Vericel	Oct 14, 2026	BUY	Strong Buy +16.3% avg upside 16 analysts	$52.00 29.09% Upside	+35.7%	·
SIBN SI-Bone	Oct 14, 2026	BUY	Strong Buy +22.8% avg upside 18 analysts	$25.00 17.70% Upside	+30.4%	·
INSP Inspire Medical Systems	Oct 14, 2026	HOLD	Hold +30.5% avg upside 21 analysts	$78.00 14.59% Upside	-9.1%	·
TFX Teleflex	Oct 14, 2026	HOLD	Buy +31.3% avg upside 20 analysts	$142.00 1.55% Upside	+25.5%	·
BSX Boston Scientific	Oct 14, 2026	BUY	Strong Buy +43.1% avg upside 38 analysts	$51.00 21.39% Upside	-0.6%	·
SYK Stryker	Oct 06, 2026	HOLD	Strong Buy +18.5% avg upside 38 analysts	$310.00 6.29% Upside	+17.1%	·
CARL Carlsmed, Inc.	Sep 29, 2026	BUY	Strong Buy +25.4% avg upside 6 analysts	—	+2.2%	·
BBNX Beta Bionics, Inc.	Sep 24, 2026	BUY	Strong Buy +45.8% avg upside 17 analysts	$28.00 67.21% Upside	-22.1%	·
MMED MiniMed Group, Inc.	Sep 24, 2026	BUY	Strong Buy +37.6% avg upside 17 analysts	$29.00 58.67% Upside	-18.2%	·
TNDM Tandem Diabetes Care	Sep 24, 2026	BUY	Buy +64.3% avg upside 29 analysts	$28.00 46.48% Upside	+19.3%	·
DXCM Dexcom	Sep 23, 2026	BUY	Strong Buy +31.4% avg upside 33 analysts	$102.00 23.95% Upside	-8.1%	·
ZBH Zimmer Biomet Holdings	Sep 16, 2026	HOLD	Hold +20.5% avg upside 39 analysts	$106.00 12.06% Upside	+12.0%	·
MDT Medtronic	Sep 02, 2026	HOLD	Buy +4.4% avg upside 38 analysts	$99.00 2.57% Upside	+11.3%	·
IRTC Irhythm Technologies	Aug 19, 2026	BUY	Strong Buy +32.2% avg upside 21 analysts	—	-28.9%	·
TMCI Treace Medical Concepts	Aug 10, 2026	HOLD	Hold +34.6% avg upside 8 analysts	$5.00 12.77% Upside	-13.7%	·
GMED Globus Medical	Aug 07, 2026	BUY	Buy +18.9% avg upside 24 analysts	$100.00 28.11% Upside	-8.8%	·
PODD Insulet	Aug 06, 2026	HOLD	Strong Buy +40.1% avg upside 32 analysts	$153.00 2.31% Upside	+5.8%	·
PRCT PROCEPT BioRobotics	Aug 05, 2026	HOLD	Buy +59.9% avg upside 18 analysts	$21.00 9.46% Upside	+16.6%	·
LNTH Lantheus	Aug 04, 2026	HOLD	Buy -19.7% avg upside 21 analysts	$102.50 2.09% Upside	-0.2%	·
ITGR Integer Holdings	Aug 04, 2026	HOLD	Buy -18.9% avg upside 16 analysts	$127.00 0.35% Upside	+1.2%	·
EW Edwards Lifesciences	Jul 24, 2026	HOLD	Strong Buy +10.0% avg upside 35 analysts	$95.00 3.23% Upside	+25.2%	·
ISRG Intuitive Surgical	Jul 17, 2026	BUY	Strong Buy +12.0% avg upside 37 analysts	$510.00 18.14% Upside	+29.6%	·
KIDS OrthoPediatrics	Mar 02, 2026	HOLD	Strong Buy +9.5% avg upside 10 analysts	$20.00 35.19% Downside	+60.2%	·
PEN Penumbra	Jan 16, 2026	HOLD	Buy +3.6% avg upside 23 analysts	$374.00 17.28% Upside	-8.7%	·
MBX MBX Biosciences, Inc.	Jan 16, 2026	BUY	Strong Buy +53.5% avg upside 14 analysts	—	+42.7%	·
IART Integra Lifesciences	Dec 23, 2025	HOLD	Buy +208.1% avg upside 22 analysts	$13.00 1.94% Upside	-12.4%	·
KYMR Kymera Therapeutics	Jun 26, 2025	BUY	Strong Buy -9.6% avg upside 39 analysts	—	+136.5%	·
RXO RXO, Inc.	Jun 18, 2025	BUY	Hold -7.5% avg upside 26 analysts	—	+64.2%	·
JAZZ Jazz Pharmaceuticals	Oct 16, 2024	BUY	Strong Buy +16.2% avg upside 36 analysts	—	+16.1%	·
KROS Keros Therapeutics	Jun 20, 2024	BUY	Strong Buy +116.5% avg upside 21 analysts	—	-70.3%	·
PGNY Progyny	Apr 17, 2024	BUY	Strong Buy +14.1% avg upside 15 analysts	—	-34.5%	·
MMM 3M	Aug 22, 2023	HOLD	Buy -0.5% avg upside 25 analysts	$148.00 15.13% Downside	+62.3%	·
ORGO Organogenesis Holdings	Oct 07, 2021	BUY	Strong Buy +1401.6% avg upside 8 analysts	—	-74.4%	·
RXST RxSight	Sep 10, 2021	BUY	Hold +86.0% avg upside 13 analysts	$20.00 310.71% Upside	+5.3%	·
CH:ALC Alcon	Aug 17, 2021	HOLD	Buy +19.4% avg upside 36 analysts	$67.55 14.39% Upside	-10.1%	·
A Agilent	Aug 06, 2021	BUY	Strong Buy -8.1% avg upside 35 analysts	—	-13.7%	·
AXGN AxoGen	Aug 05, 2021	BUY	Strong Buy -17.4% avg upside 21 analysts	$27.00 45.24% Downside	-45.5%	·
LNSR LENSAR	Aug 05, 2021	BUY	Strong Buy +135.4% avg upside 4 analysts	$20.00 242.54% Upside	-24.4%	·
BDX Becton Dickinson	Aug 05, 2021	HOLD	Buy -0.4% avg upside 25 analysts	$250.00 26.38% Upside	+8.6%	·
CNMD Conmed	Jul 28, 2021	HOLD	Hold +48.7% avg upside 12 analysts	$141.00 218.37% Upside	-27.9%	·
ALGN Align Tech	Jul 28, 2021	BUY	Strong Buy +89.9% avg upside 21 analysts	$770.00 413.67% Upside	-54.6%	·
ATRC Atricure	Jul 15, 2016	BUY	Strong Buy -13.7% avg upside 15 analysts	$20.00 67.33% Downside	+59.5%	·
SENS Senseonics Holdings	Jul 15, 2016	BUY	Buy +58.2% avg upside 13 analysts	$4.50 52.64% Downside	-41.3%	·
JNJ Johnson & Johnson	Jul 15, 2016	BUY	Strong Buy -9.1% avg upside 40 analysts	$140.00 48.66% Downside	+10.7%	·
BAX Baxter International	Jul 15, 2016	HOLD	Buy +45.3% avg upside 23 analysts	$47.00 104.35% Upside	+34.3%	·
ABT Abbott Laboratories	Jul 15, 2016	HOLD	Strong Buy +8.6% avg upside 36 analysts	$45.00 57.60% Downside	+19.0%	·

🔒 42 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Richard Newitter — Frequently Asked Questions

How accurate are Richard Newitter's stock ratings?

Based on the calls 13Foresight could measure, about 59% of Richard's ratings were profitable over a one-year hold, with an average return of +5.9% per rating, or +26.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Richard ranked on 13Foresight?

Richard Newitter is currently ranked #1630 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Richard cover?

Richard most recently has ratings on GKOS, VCEL, SIBN, INSP, TFX, BSX, SYK, CARL, BBNX, MMED, TNDM, DXCM and 35 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Richard Newitter

Rating Distribution

Welcome to 13Foresight!